Alpine Immune Sciences (NASDAQ:ALPN) just reported results for the fourth quarter of 2023.
- Alpine Immune Sciences reported earnings per share of 15 cents. This was above the analyst estimate for EPS of -34 cents.
- The company reported revenue of $30.85 million.
- This was 239.04% better than the analyst estimate for revenue of $9.10 million.